Human neutrophil α‐defensin 4 inhibits HIV‐1 infection in vitro
- 2 December 2004
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (1), 162-166
- https://doi.org/10.1016/j.febslet.2004.11.062
Abstract
Human neutrophil α‐defensin 4 (HNP4) is more effective than HNP1–3 in protecting human peripheral blood mononuclear cells from infection by both X4 and R5 HIV‐1 strains. HNP4 binds to both CD4 and gp120 approximately two orders of magnitude weaker than does HNP1, and is less effectively sequestered by glycosylated serum proteins than HNP1. These results suggest that the HIV‐1 inhibition by HNP4 stems at least partially from a unique and lectin‐independent property of HNP4 with CD4 and/or gp120. Our finding identifies an anti‐HIV‐1 property of HNP4 and may have implications in the development of new antiviral agents for AIDS therapy.Keywords
This publication has 36 references indexed in Scilit:
- The θ-Defensin, Retrocyclin, Inhibits HIV-1 EntryAIDS Research and Human Retroviruses, 2003
- α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factorsAIDS, 2003
- CAF-Mediated Human Immunodeficiency Virus (HIV) Type 1 Transcriptional Inhibition Is Distinct from α-Defensin-1 HIV InhibitionJournal of Virology, 2003
- Productive Folding of Human Neutrophil α-Defensins in Vitro without the Pro-peptideJournal of the American Chemical Society, 2003
- Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2Science, 2002
- Antimicrobial peptides of multicellular organismsNature, 2002
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984